146
Views
19
CrossRef citations to date
0
Altmetric
Review

Medical treatment of diabetic retinopathy with somatostatin analogues

, , &
Pages 73-82 | Published online: 07 Dec 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Massimo Dal Monte & Giovanni Casini. (2016) Indirect blockade of vascular endothelial growth factor: the potential for eye disease therapy. Expert Review of Ophthalmology 11:1, pages 1-4.
Read now
Rakesh Chibber, Surina Chibber & Eva M Kohner. (2007) 21st Century treatment of diabetic retinopathy. Expert Review of Endocrinology & Metabolism 2:5, pages 623-631.
Read now
Barbara Eden Kobrin Klein. (2007) Overview of Epidemiologic Studies of Diabetic Retinopathy. Ophthalmic Epidemiology 14:4, pages 179-183.
Read now

Articles from other publishers (16)

Akiko Yuno, Akemi Ikota, Shigeki Koizumi, Yasuo Mashio, Hiroko Imaizumi, Yutaka Sawamura & Akira Shimatsu. (2022) Advanced proliferative diabetic retinopathy and macular edema in acromegaly: a case report and literature review. Diabetology International 13:3, pages 575-579.
Crossref
Olga Simó-Servat, Cristina Hernández & Rafael Simó. (2018) Somatostatin and diabetic retinopathy: an evolving story. Endocrine 60:1, pages 1-3.
Crossref
S. Feldman-Billard, É. Larger & P. Massin. (2018) Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes & Metabolism 44:1, pages 4-14.
Crossref
Sara Rezzola, Mirella Belleri, Giuseppina Gariano, Domenico Ribatti, Ciro Costagliola, Francesco Semeraro & Marco Presta. (2013) In vitro and ex vivo retina angiogenesis assays. Angiogenesis 17:3, pages 429-442.
Crossref
Cristina Hernández, Olga Simó-Servat & Rafael Simó. (2014) Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives. Endocrine 46:2, pages 209-214.
Crossref
Shuang Wang, James K. Park & Elia J. Duh. (2012) Novel Targets Against Retinal Angiogenesis in Diabetic Retinopathy. Current Diabetes Reports 12:4, pages 355-363.
Crossref
Massimo Dal Monte, Valentina Latina, Elena Cupisti & Paola Bagnoli. (2012) Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. Naunyn-Schmiedeberg's Archives of Pharmacology 385:5, pages 481-494.
Crossref
Scott E. Wolkenberg, Zhijian Zhao, Catherine Thut, Jill W. Maxwell, Terrence P. McDonald, Fumi Kinose, Michael Reilly, Craig W. Lindsley & George D. Hartman. (2011) Design, Synthesis, and Evaluation of Novel 3,6-Diaryl-4-aminoalkoxyquinolines as Selective Agonists of Somatostatin Receptor Subtype 2. Journal of Medicinal Chemistry 54:7, pages 2351-2358.
Crossref
Scott E. Pautler. 2010. Diabetic Retinopathy. Diabetic Retinopathy 227 304 .
Carmen Clapp, Stéphanie Thebault, Michael C. Jeziorski & Gonzalo Martínez De La Escalera. (2009) Peptide Hormone Regulation of Angiogenesis. Physiological Reviews 89:4, pages 1177-1215.
Crossref
Anna Vasilaki & Kyriaki Thermos. (2009) Somatostatin analogues as therapeutics in retinal disease. Pharmacology & Therapeutics 122:3, pages 324-333.
Crossref
Davide Cervia, Giovanni Casini & Paola Bagnoli. (2008) Physiology and pathology of somatostatin in the mammalian retina: A current view. Molecular and Cellular Endocrinology 286:1-2, pages 112-122.
Crossref
C. Hernández Pascual, J. Giralt Josa & R. Simó Canonge. (2008) Tratamiento de la retinopatía diabética. Endocrinología y Nutrición 55, pages 92-98.
Crossref
Alexander V. Ljubimov, Michael E. Boulton, Sergio Caballero & Maria B. Grant. 2008. Diabetic Retinopathy. Diabetic Retinopathy 449 463 .
A. Afzal, L.C. Shaw, A.V. Ljubimov, M.E. Boulton, M.S. Segal & M.B. Grant. (2007) Retinal and choroidal microangiopathies: Therapeutic opportunities. Microvascular Research 74:2-3, pages 131-144.
Crossref
Adam Greenstein, Mitra Tavakoli, Moaz Mojaddidi, Ahmed Al-Sunni, Glenn Matfin & Rayaz A Malik. (2016) Review: Microvascular complications: evaluation and monitoring relevance to clinical practice, clinical trials, and drug development. The British Journal of Diabetes & Vascular Disease 7:4, pages 166-171.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.